Onyx Pharmaceuticals, Inc., An Amgen Subsidiary

Onyx Pharmaceuticals, Inc., An Amgen Subsidiary company information, Employees & Contact Information

Formerly based in South San Francisco, California, Onyx Pharmaceuticals was engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer. Amgen acquired Onyx Pharmaceuticals in 2013. See our Community Guidelines: bit.ly/smcgl

Company Details

Employees
190
Founded
-
Address
249 E. Grand Avenue, South San Francisco,ca 94080,united States
Phone
(650) 266-0000
Industry
Biotechnology
HQ
South San Francisco, CA
Looking for a particular Onyx Pharmaceuticals, Inc., An Amgen Subsidiary employee's phone or email?

Onyx Pharmaceuticals, Inc., An Amgen Subsidiary Questions

News

Xencor Appoints Raymond Deshaies, Ph.D., to Board of Directors - Business Wire

Xencor Appoints Raymond Deshaies, Ph.D., to Board of Directors Business Wire

Onyx Pharma Q4 Loss Narrows On Higher Nexavar Sales - Update - RTTNews

Onyx Pharma Q4 Loss Narrows On Higher Nexavar Sales - Update RTTNews

Amgen's Acquisition Of Onyx Pharmaceuticals — Through The Eyes Of Tony Coles - Life Science Leader

Amgen's Acquisition Of Onyx Pharmaceuticals — Through The Eyes Of Tony Coles Life Science Leader

A Look at Amgen and Its $10 Billion Flop Onyx - BioSpace

A Look at Amgen and Its $10 Billion Flop Onyx BioSpace

Onyx Pharma Will Pay Up To $851M For Proteolix - CBS News

Onyx Pharma Will Pay Up To $851M For Proteolix CBS News

2024 Transformational Leadership Award N. Anthony Coles, MD'86, MPH - Duke School of Medicine

2024 Transformational Leadership Award N. Anthony Coles, MD'86, MPH Duke School of Medicine

Amgen buying drugmaker Onyx for about $10B - USA Today

Amgen buying drugmaker Onyx for about $10B USA Today

Pharma Firms Make Biotech Staff Cuts - Chemical & Engineering News

Pharma Firms Make Biotech Staff Cuts Chemical & Engineering News

Amgen swallows Onyx whole - Nature

Amgen swallows Onyx whole Nature

Amgen close to buying Onyx for $125 per share - CNBC

Amgen close to buying Onyx for $125 per share CNBC

Bayer Healthcare, Onxy Pharma gets USFDA OK for Stivarga tablets - Healthcare Digital

Bayer Healthcare, Onxy Pharma gets USFDA OK for Stivarga tablets Healthcare Digital

Amgen To Acquire Onyx, Maker Of Kyprolis; What Does It Mean For The Myeloma Community? - The Myeloma Beacon

Amgen To Acquire Onyx, Maker Of Kyprolis; What Does It Mean For The Myeloma Community? The Myeloma Beacon

Nexavar shown to significantly extend survival for patients with advanced liver cancer - EurekAlert!

Nexavar shown to significantly extend survival for patients with advanced liver cancer EurekAlert!

Onyx Scientific Opens Second Facility in Sunderland, UK - Contract Pharma

Onyx Scientific Opens Second Facility in Sunderland, UK Contract Pharma

GEN’s List of Top Pharma and Biotech Firms - Genetic Engineering and Biotechnology News

GEN’s List of Top Pharma and Biotech Firms Genetic Engineering and Biotechnology News

California Court Broadens a D&O Policy’s Bump-Up Exclusion to Bump Out Coverage (Insurance) - Lowenstein Sandler LLP

California Court Broadens a D&O Policy’s Bump-Up Exclusion to Bump Out Coverage (Insurance) Lowenstein Sandler LLP

Onyx Pharmaceuticals Slips To Loss In Q1 - Quick Facts - RTTNews

Onyx Pharmaceuticals Slips To Loss In Q1 - Quick Facts RTTNews

Onyx To Buy Proteolix - Chemical & Engineering News

Onyx To Buy Proteolix Chemical & Engineering News

Onyx Pharmaceuticals To Acquire Proteolix, Developer Of Carfilzomib - The Myeloma Beacon

Onyx Pharmaceuticals To Acquire Proteolix, Developer Of Carfilzomib The Myeloma Beacon

Nexavar significantly extends overall survival by 44 percent in liver cancer patients - EurekAlert!

Nexavar significantly extends overall survival by 44 percent in liver cancer patients EurekAlert!

Bradway’s patient dealmaking brings Onyx to Amgen - South China Morning Post

Bradway’s patient dealmaking brings Onyx to Amgen South China Morning Post

Google unit stakes biotech claim with lease of entire Onyx campus - The Business Journals

Google unit stakes biotech claim with lease of entire Onyx campus The Business Journals

Making A Difference Matters - Life Science Leader

Making A Difference Matters Life Science Leader

D.E Shaw's Onxy Pharma Stake Looking Good After Company Has Major Cancer Drug Success - businessinsider.com

D.E Shaw's Onxy Pharma Stake Looking Good After Company Has Major Cancer Drug Success businessinsider.com

Pfizer Doesn't Want To Bid On A Surging Onyx: Report - International Business Times

Pfizer Doesn't Want To Bid On A Surging Onyx: Report International Business Times

Pharma Sector: Few Newsmakers Of The Week - Glaxo, Pfizer, Lilly, IDM Pharma, Onyx, Mylan, OSI Pharma, Ziopharm - RTTNews

Pharma Sector: Few Newsmakers Of The Week - Glaxo, Pfizer, Lilly, IDM Pharma, Onyx, Mylan, OSI Pharma, Ziopharm RTTNews

Feds say Astellas, Amgen will fork over $125M to settle charity kickback probes - Fierce Pharma

Feds say Astellas, Amgen will fork over $125M to settle charity kickback probes Fierce Pharma

Amgen's Kyprolis, J&J's Darzalex team up on myeloma survival win - Fierce Pharma

Amgen's Kyprolis, J&J's Darzalex team up on myeloma survival win Fierce Pharma

Array BioPharma reaches agreement with Novartis PharmaAG - The Cancer Letter

Array BioPharma reaches agreement with Novartis PharmaAG The Cancer Letter

Bayer, Dr. Reddy's end patent dispute over generic of cancer drug Nexavar - Reuters

Bayer, Dr. Reddy's end patent dispute over generic of cancer drug Nexavar Reuters

Amgen's Kyprolis stands its ground against new J&J, BMS rivals - Fierce Pharma

Amgen's Kyprolis stands its ground against new J&J, BMS rivals Fierce Pharma

FibroGen Strengthens Board with Velcade Developer: Key Move for Pipeline Advancement - Stock Titan

FibroGen Strengthens Board with Velcade Developer: Key Move for Pipeline Advancement Stock Titan

Amgen exec: Don't blame J&J rival Darzalex for Kyprolis' latest sales shortfall - Fierce Pharma

Amgen exec: Don't blame J&J rival Darzalex for Kyprolis' latest sales shortfall Fierce Pharma

Sterile products supplier Onyx Biotec to open its IPO for subscription on November 13 - Moneycontrol

Sterile products supplier Onyx Biotec to open its IPO for subscription on November 13 Moneycontrol

Nexavar - First FDA-Approved Drug Therapy for Liver Cancer - Mynewsdesk

Nexavar - First FDA-Approved Drug Therapy for Liver Cancer Mynewsdesk

Domain investor paid $250,000 for Onyx.com this year - Domain Name Wire

Domain investor paid $250,000 for Onyx.com this year Domain Name Wire

Pacira Announces Updates to Board of Directors - GlobeNewswire

Pacira Announces Updates to Board of Directors GlobeNewswire

Sentences Handed Down To Massachusetts Pair In Counterfeit Steroid Ring - Partnership for Safe Medicines

Sentences Handed Down To Massachusetts Pair In Counterfeit Steroid Ring Partnership for Safe Medicines

India Orders Bayer to License a Patented Drug (Published 2012) - The New York Times

India Orders Bayer to License a Patented Drug (Published 2012) The New York Times

Top Onyx Pharmaceuticals, Inc., An Amgen Subsidiary Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant